5 news items
Soligenix, Inc. Announces Adjournment of Annual Meeting, Information for Reconvened Annual Meeting
SNGX
24 May 24
at the Annual Meeting is a majority of the voting power of shares
Soligenix Extends Patent Protection for its Filovirus Vaccine Platform to the United Kingdom and South Africa
SNGX
25 Apr 24
."
"Our next generation combined vaccine platform includes three major components: a robust protein manufacturing process that has
Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session
ADIL
AEYE
ATHE
15 Apr 24
announced that it sold its majority interest in Utah Hospitals.
CareMax, Inc
FDA Grants Soligenix Orphan Drug Designation for the Prevention and Post-Exposure Prophylaxis Against Sudan Ebolavirus Infection
SNGX
11 Apr 24
.
"SuVax™ is based on our novel vaccine platform which includes three major components: a robust protein
Soligenix Announces Agreement on the Design of a Second Confirmatory Placebo-Controlled Trial for HyBryte™ With the European Medicines Agency
SNGX
3 Apr 24
."
"With its chronic course and major impact on patient quality of life, CTCL is an orphan disease in urgent need
- Prev
- 1
- Next